MedTrace Logo

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

NCT06843512 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-09-10

No results posted yet for this study

Summary

In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.

Conditions

Interventions

OTHER

GLP-1 Medication Initiation

One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits.

Sponsors & Collaborators

  • Penn State University

    lead OTHER

Principal Investigators

  • Travis Masterson · The Pennsylvania State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-15
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06843512 on ClinicalTrials.gov